Evidence map›Paper›PMID 29580293›Full record

ArticleSystematic reviews2018

Effects of oncological care pathways in primary and secondary care on patient, professional, and health systems outcomes: protocol for a systematic review and meta-analysis.

Jolanda C van Hoeve, Robin W M Vernooij, Adegboyega K Lawal, Michelle Fiander, Peter Nieboer, Sabine Siesling, Thomas Rotter

Open access · goldAbstract read
In one paragraph

Article in Systematic reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Jolanda C van HoeveDepartment Health Technology and Services Research (HTSR), University of Twente, P.O. Box 217, 7500 AE, Enschede, the Netherlands. j.c.vanhoeve@utwente.nl.
Robin W M VernooijNetherlands Comprehensive Cancer Organisation (IKNL), P.O. Box 19079, 3501 DB, Utrecht, the Netherlands.
Adegboyega K LawalCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada.
Michelle FianderCollege of Pharmacy, Department of Pharmacology, University of Utah, Salt Lake City, USA.
Peter NieboerWilhelmina Hospital, Assen, the Netherlands.
Sabine SieslingDepartment Health Technology and Services Research (HTSR), University of Twente, P.O. Box 217, 7500 AE, Enschede, the Netherlands.
Thomas RotterHealthcare Quality Programs, School of Nursing, Queen's University, Kingston, Ontario, Canada.
Netherlands Comprehensive Cancer Organisation · NLQueen's University · CAUniversity of Saskatchewan · CAUniversity of Twente · NLUniversity of Utah · USWilhelmina Children's Hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe high impact of a cancer diagnosis on patients and their families and the increasing costs of cancer treatment call for optimal and efficient oncological care. To improve the quality of care and to minimize healthcare costs and its economic burden, many healthcare organizations introduce care pathways to improve efficiency across the continuum of cancer care. However, there is limited research on the effects of cancer care pathways in different settings.

methodsThe aim of this systematic review and meta-analysis described in this protocol is to synthesize existing literature on the effects of oncological care pathways. We will conduct a systematic search strategy to identify all relevant literature in several biomedical databases, including Cochrane library, MEDLINE, Embase, and CINAHL. We will follow the methodology of Cochrane Effective Practice and Organisation of Care (EPOC), and we will include randomized trials, non-randomized trials, controlled before-after studies, and interrupted time series studies. In addition, we will include full economic evaluations (cost-effectiveness analyses, cost-utility analyses, and cost-benefit analyses), cost analyses, and comparative resource utilization studies, if available. Two reviewers will independently screen all studies and evaluate those included for risk of bias. From these studies, we will extract data regarding patient, professional, and health systems outcomes. Our systematic review will follow the PRISMA set of items for reporting in systematic reviews and meta-analyses. DISCUSSION: Following the protocol outlined in this article, we aim to identify, assess, and synthesize all available evidence in order to provide an evidence base on the effects of oncological care pathways as reported in the literature. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017057592 .

Indexed as

Continuity of Patient CareCritical PathwaysMedical OncologyPrimary Health CareSecondary Health CareDelivery of Health Care, IntegratedEfficiency, OrganizationalHealth Care CostsHumansMeta-Analysis as TopicSystematic Reviews as TopicCancerCare mapsCare pathwaysClinical pathwaysIntegrated care pathwaysOncologySystematic reviews

Identifiers

PMID29580293
PMCPMC5870525
OpenAlexW2796601932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.